Meet the Division of Cancer Biology Investigators
The Division of Cancer Biology (DCB) supports basic cancer researchers who are advancing our fundamental understanding of cancer. Their basic science discoveries lay the foundation for the important breakthroughs in the prevention and treatment of cancer.
-
Dr. Anirban Maitra is Advancing Early Detection and Cancer Interception in Pancreatic Tumors
Dr. Maitra shares his research focusing on mechanisms of pancreatic cancer and discusses the importance of studying basic cancer biology.
-
Dr. Renee Brady Develops Mathematical Models to Improve Cancer Treatments
Dr. Brady develops mathematical models to predict patient-specific responses to cancer therapy. She also describes how interactions with patient advocates have helped her cancer research.
-
Dr. Jennifer Wargo Investigates the Role of the Microbiome in Immunotherapy Responses
Dr. Wargo’s research examines the role of the gut microbiome in cancer immunotherapy response. Learn how a lab mishap led her to investigate the microbiome’s role in response to cancer treatment.
-
Dr. Bill Kaelin Studies Tumor Suppressors to Improve the Understanding of Cancer Biology
Dr. Kaelin shares his work focusing on tumor suppressor proteins, including his studies of von Hippel-Lindau (VHL) for which he was awarded the 2019 Nobel Prize in Physiology or Medicine.
-
Dr. Karuna Ganesh is Investigating and Targeting Mechanisms of Cancer Metastasis
Dr. Ganesh discusses her research using patient-derived organoids to study the complex processes of metastasis.
-
Dr. Andrew Gentles Creates Computational Tools to Advance Cancer Systems Biology
Dr. Gentles explains the importance of computational biology for cancer research and describes how his lab uses systems approaches to investigate the tumor microenvironment.
-
Dr. Suzanne Baker is Determining Drivers of Pediatric Brain Cancer to Inform the Development of Therapies
Dr. Baker shares her research investigating biological mechanisms of pediatric brain tumors, which contributes to the design of clinical trials and development of anti-cancer therapies.